1. Home
  2. CKPT vs LND Comparison

CKPT vs LND Comparison

Compare CKPT & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKPT
  • LND
  • Stock Information
  • Founded
  • CKPT 2014
  • LND 2005
  • Country
  • CKPT United States
  • LND Brazil
  • Employees
  • CKPT N/A
  • LND N/A
  • Industry
  • CKPT Biotechnology: Pharmaceutical Preparations
  • LND Farming/Seeds/Milling
  • Sector
  • CKPT Health Care
  • LND Consumer Staples
  • Exchange
  • CKPT Nasdaq
  • LND Nasdaq
  • Market Cap
  • CKPT 361.1M
  • LND 367.6M
  • IPO Year
  • CKPT 2017
  • LND 2006
  • Fundamental
  • Price
  • CKPT $4.26
  • LND $3.78
  • Analyst Decision
  • CKPT Buy
  • LND
  • Analyst Count
  • CKPT 3
  • LND 0
  • Target Price
  • CKPT $4.33
  • LND N/A
  • AVG Volume (30 Days)
  • CKPT 2.1M
  • LND 31.4K
  • Earning Date
  • CKPT 05-13-2025
  • LND 06-10-2025
  • Dividend Yield
  • CKPT N/A
  • LND 6.61%
  • EPS Growth
  • CKPT N/A
  • LND 29.70
  • EPS
  • CKPT N/A
  • LND 0.54
  • Revenue
  • CKPT $41,000.00
  • LND $214,643,237.00
  • Revenue This Year
  • CKPT $102,182.93
  • LND $55.76
  • Revenue Next Year
  • CKPT $351.71
  • LND N/A
  • P/E Ratio
  • CKPT N/A
  • LND $6.78
  • Revenue Growth
  • CKPT N/A
  • LND 8.74
  • 52 Week Low
  • CKPT $1.80
  • LND $3.49
  • 52 Week High
  • CKPT $4.50
  • LND $5.14
  • Technical
  • Relative Strength Index (RSI)
  • CKPT 80.26
  • LND 49.75
  • Support Level
  • CKPT $4.14
  • LND $3.71
  • Resistance Level
  • CKPT $4.20
  • LND $3.77
  • Average True Range (ATR)
  • CKPT 0.03
  • LND 0.08
  • MACD
  • CKPT -0.00
  • LND 0.01
  • Stochastic Oscillator
  • CKPT 85.71
  • LND 70.83

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: